1. Fukuda T, Setoguchi M, Morimoto Y, Shoji H, Tumagari T, Maruyama Y. Neuroleptic properties of Y-516, a new iminodibenzyl derivative. Folia Pharmacol Jpn. 1985;86:197–208.
2. Harada T. From the discovery of antimanic effect to the recent positioning as a novel atypical neuroleptic. Jpn J Clin Psychopharmacol. 1998;1:1187–93. (in Japanese, Abstract in English).
3. Imai H, Nakamura M, Hukui Y, Tanaka K, Mori M, Hukui K, et al. Comparison of efficacy of zotepine and perphenazine in schizophrenia by double-blind, controlled study. Jpn J Neuropsychopharmacol. 1980;2:285–99. (in Japanese, Abstract in English).
4. Inanaga K, Nakamura J, Takahashi R, Ootsuki SM, Samejima K, Sarai K, et al. Comparison of anti-manic efficacy of timiperone injection and haloperidol injection by double-blind controlled study. J Clin Med. 1985;1:1329–44. (in Japanese, Abstract in English).
5. Iwanaga M, Akazawa S, Abe T, Arai H, Ando K, Ichimiya H, et al. Clinical evaluation of zotepine in chronic schizophrenia – a multi-institutional double-blind study in comparison with propericiazine. Jpn J Clin Psychiatry. 1980;9:873–91. (in Japanese).